I agree that this site is using cookies. You can find further informations here.
X
Mouw, K.
154  results:
Search for persons X
?
1

Retraction Note: Oncogenic targeting of BRM drives malignan..:

Damiano, L. ; Stewart, K. M. ; Cohet, N....
Oncogene.  43 (2024)  14 - p. 1076-1076 , 2024
Link: https://doi.org/10.1038/..
 
?
2

ATM loss and therapeutic vulnerabilities in bladder cancer:

Mouw, K. ; Zhou, Y. ; Adib, E....
European Urology Open Science.  45 (2022)  - p. S218 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Subpopulation targeting of pyruvate dehydrogenase and GLUT1..:

Commander, R. ; Wei, C. ; Sharma, A....
Nature Communications.  11 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
4

Preclinical Models of DNA Repair Deficiency in Prostate Can..:

Fitzpatrick, K. ; Hwang, J. ; Cai, M.Y....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e156 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Androgen Deprivation Therapy and Overall Survival for Gleas..:

Yang, D.D. ; Mahal, B.A. ; Muralidhar, V....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. S145 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Whole-Pelvic Versus Prostate-Only Radiation Therapy in Unfa..:

Yang, D.D. ; Mahal, B.A. ; Muralidhar, V....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e150-e151 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Impact of Percent Positive Biopsy Cores on Cancer-Specific ..:

Yang, D.D. ; Muralidhar, V. ; Mahal, B.A....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e150 , 2018
Link: https://doi.org/10.1016/..
 
?
8

The Immune Milieu of Anal Squamous Cell Carcinoma: IDO Expr..:

Mitra, D. ; Horick, N. ; Brackett, D....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e13 , 2018
Link: https://doi.org/10.1016/..
 
?
9

OC-0049: Genomic profiling of muscle invasive bladder cance..:

Miyamoto, D. ; Gibb, E. ; Mouw, K....
Radiotherapy and Oncology.  127 (2018)  - p. S21 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Virtual PSA Monitoring Program Pilot: The Integration of Te..:

Boyajian, R. ; Simeoli, A. ; Orio III, P.F....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e101-e102 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Mapping the Functional Landscape of ERCC2 Mutations in Musc..:

Frazier, Z. ; Damish, A. ; Reznichenko, E....
International Journal of Radiation Oncology*Biology*Physics.  99 (2017)  2 - p. S32-S33 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Subtyping Muscle-Invasive Bladder Cancer to Assess Clinical..:

Efstathiou, J.A. ; Gibb, E. ; Miyamoto, D.T....
International Journal of Radiation Oncology*Biology*Physics.  99 (2017)  2 - p. S118 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Somatic ERCC2 Mutations Are Associated With a Distinct Muta..:

Mouw, K. ; Braunstein, L.Z. ; Kim, J....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. S54 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Genomic Analysis of Chemoradiation Therapy Response in Anal..:

Mouw, K. ; Amin-Mansour, A. ; Braunstein, L.Z....
International Journal of Radiation Oncology*Biology*Physics.  93 (2015)  3 - p. S124-S125 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Somatic ERCC2 Mutations Confer Cisplatin Sensitivity in Mus..:

Mouw, K. ; Van Allen, E. ; O'Connor, K....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  1 - p. S88 , 2014
Link: https://doi.org/10.1016/..
 
1-15